You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vandetanib

Showing 26 - 50 of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Hepatocellular Trial in Tainan, Taipei, Taoyuan (Vandetanib, Best Supportive Care)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Vandetanib
  • Best Supportive Care
  • Tainan, Taiwan
  • +2 more
Aug 29, 2016

Ovarian Cancer Trial in Germany (Vandetanib)

Terminated
Has Results
  • Ovarian Cancer
  • Vandetanib
  • Ulm, Baden-Württemberg, Germany
  • +4 more
Aug 29, 2016

Mesothelioma Trial in Germany, Switzerland (Vinorelbine, Vandetanib)

Terminated
Has Results
  • Mesothelioma
  • Essen, Germany
  • +5 more
Aug 29, 2016

Prostate Cancer Trial in Canada (vandetanib, Placebo)

Terminated
Has Results
  • Prostate Cancer
  • vandetanib
  • Placebo
  • Calgary, Alberta, Canada
  • +10 more
Oct 27, 2016

Healthy Volunteers Trial in Overland Park (Digoxin, Vandetanib)

Completed
  • Healthy Volunteers
  • Overland Park, Kansas
    Research Site
Aug 26, 2016

Healthy Volunteers Trial in Overland Park (Midazolam, vandetanib)

Completed
  • Healthy Volunteers
  • Overland Park, Kansas
    Research Site
Aug 26, 2016

NSCLC Trial in Korea, Republic of (Vandetanib, Placebo)

Completed
Has Results
  • NSCLC
  • Vandetanib
  • Placebo
  • CheongJu, Republic of Korea, Korea, Republic of
  • +4 more
Aug 29, 2016

Non Small Cell Lung Cancer Trial in Worldwide (Vandetanib, Erlotinib)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Berkeley, California
  • +152 more
Jan 24, 2018

Advanced Solid, Malignant Tumors Trial in Guangzhou (Vandetanib, Vandetanib 300 mg)

Completed
  • Advanced Solid, Malignant Tumors
  • Vandetanib
  • Vandetanib 300 mg
  • Guangzhou, China
    Research Site
Aug 29, 2016

Pancreatic Cancer Trial in St Gallen, Bellinzona (Vandetanib)

Completed
  • Pancreatic Cancer
  • Vandetanib
  • St Gallen, SG, Switzerland
  • +1 more
Aug 26, 2016

Gastrointestinal Cancers Trial in Guangzhou (Erlotinib or Gefitinib, Everolimus, Imatinib)

Unknown status
  • Gastrointestinal Cancers
  • Erlotinib or Gefitinib
  • +4 more
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yat-sen University
Aug 27, 2016

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (docetaxel, vandetanib)

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • Mobile, Alabama
  • +136 more
Oct 26, 2016

Colorectal Cancer Trial in Worldwide (Vandetanib, FOLFIRI)

Completed
Has Results
  • Colorectal Cancer
  • Ann Arbor, Michigan
  • +21 more
Aug 25, 2016

Advanced Clear Cell Renal Carcinoma Trial run by the NCI (vandetanib)

Terminated
Has Results
  • Advanced Clear Cell Renal Carcinoma
  • vandetanib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 2, 2015

NSCLC, Lung Cancer Trial in Worldwide (Docetaxel, Vandetanib)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Lung Cancer
  • Fullerton, California
  • +156 more
Aug 24, 2016

Lung Cancer Trial in Canada (vandetanib, adjuvant therapy)

Completed
  • Lung Cancer
  • vandetanib
  • adjuvant therapy
  • Calgary, Alberta, Canada
  • +20 more
Aug 23, 2016

Tumors Trial in United Kingdom (Fulvestrant, Vandetanib)

Unknown status
  • Neoplasms
  • Bournemouth, Dorset, United Kingdom
  • +4 more
Aug 19, 2015

Glioblastoma Trial in Boston (Sirolimus, Vandetanib)

Completed
  • Glioblastoma
  • Boston, Massachusetts
  • +1 more
Apr 30, 2015

Head Neck Cancer Trial in United States (cisplatin, vandetanib, radiation therapy)

Terminated
Has Results
  • Head and Neck Cancer
  • Scottsdale, Arizona
  • +62 more
Nov 14, 2015

Gastric Cancer Trial in Buffalo (docetaxel, vandetanib)

Terminated
Has Results
  • Gastric Cancer
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 29, 2014

Solid Tumor Trial (temozolomide, vandetanib, immunoenzyme technique)

Withdrawn
  • Unspecified Adult Solid Tumor, Protocol Specific
  • (no location specified)
Mar 6, 2014

Advanced Incurable Solid Malignancy Trial in Pittsburgh (Vandetanib, Gemcitabine, Oxaliplatin)

Completed
  • Advanced Incurable Solid Malignancy
  • Vandetanib
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute / Hillman Cancer Cente
Jan 21, 2014

Metastatic Breast Cancer Trial in Boston (Vandetanib, Cyclophosphamide, Methotrexate)

Completed
  • Metastatic Breast Cancer
  • Vandetanib
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2013

Malignant Gliomas Trial in Aurora (Vandetanib, Fractionated Stereotactic Radiotherapy)

Completed
  • Malignant Gliomas
  • Vandetanib
  • Fractionated Stereotactic Radiotherapy
  • Aurora, Colorado
    University of Colorado Health Science Center
Jun 24, 2013

Prostate Cancer Trial in Canada (Vandetanib, Bicalutamide)

Completed
  • Prostate Cancer
  • Kelowna, British Columbia, Canada
  • +3 more
Feb 19, 2013